Toric Trifocal IOL Treatment With High Astigmatism and Hyperopia vs SMILE Enhancement After Trifocal IOL Treatment

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

June 1, 2019

Study Completion Date

June 15, 2020

Conditions
Astigmatism High BothPseudophakiaHyperopia
Interventions
PROCEDURE

Toric Trifocal IOL

Interventions are performed using a standard technique of sutureless phacoemulsification. In all cases, topical anesthesia was administered and pharmacologic mydriasis was induced using a combination of tropicamide and phenylephrine (10.0%). A mean clear corneal microincision of 2.2 mm was made with a knife according to position of the preop highest K value of the patient. A paracentesis was made 60 degree to 80 degree, clockwise from the main incision, and the anterior chamber was filled with an ophthalmic viscoelastic (OVD) after phacoemulsification/lensectomy and removal of clear lens. The IOL was subsequently implanted through the main incision using the BLUEMIXS 180 injector (Carl Zeiss meditec, Jena, Germany) for trifocal IOL , VISCOJECTTM BIO injector for toric trifocal IOL and then the OVD was removed. Postoperative pharmacologic treatment is performed with the combination of antibiotic and steroidal anti-inflammatory drops

Trial Locations (1)

10000

Eye Hospital Pristina, Pristina

All Listed Sponsors
lead

Eye Hospital Pristina Kosovo

OTHER

NCT04468022 - Toric Trifocal IOL Treatment With High Astigmatism and Hyperopia vs SMILE Enhancement After Trifocal IOL Treatment | Biotech Hunter | Biotech Hunter